Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 251,013 | 228,364 | 223,986 | 221,441 | 201,813 |
| Receivables | 159,119 | 158,988 | 138,324 | 141,374 | 147,159 |
| Inventories | 140,938 | 148,242 | 140,946 | 147,474 | 143,703 |
| Income taxes - deferred | 26,372 | 25,719 | 27,714 | 25,430 | 25,118 |
| Other current assets | 37,460 | 33,082 | 38,567 | 35,055 | 37,514 |
| TOTAL | $614,902 | $594,395 | $569,537 | $570,774 | $555,307 |
| Non-Current Assets | |||||
| PPE Net | 266,494 | 253,742 | 245,177 | 231,639 | 220,580 |
| Investments And Advances | 0 | 51,006 | 0 | 0 | 0 |
| Intangibles | 58,103 | 233,495 | 237,827 | 63,363 | 235,556 |
| Other Non-Current Assets | 224,572 | 0 | 51,061 | 227,575 | 55,874 |
| TOTAL | $549,169 | $538,243 | $534,065 | $522,577 | $512,010 |
| Total Assets | $1,164,071 | $1,132,638 | $1,103,602 | $1,093,351 | $1,067,317 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,137 | 1,122 | 1,107 | 960 | 945 |
| Accounts payable and accrued liabilities | 37,584 | 38,716 | 35,288 | 31,728 | 29,706 |
| Accrued Expenses | 123,470 | 118,470 | 137,746 | 134,664 | 128,478 |
| TOTAL | $551,671 | $439,577 | $406,333 | $415,846 | $419,151 |
| Non-Current Liabilities | |||||
| Long Term Debt | 884 | 1,141 | 1,394 | 1,776 | 2,021 |
| Deferred Revenues | 21,980 | 21,269 | 20,192 | 16,494 | 16,022 |
| Other Non-Current Liabilities | 25,756 | 24,812 | 23,892 | 22,868 | 21,257 |
| TOTAL | $62,809 | $61,766 | $61,012 | $59,970 | $58,225 |
| Total Liabilities | $614,480 | $501,343 | $467,345 | $475,816 | $477,376 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,086 | 108,206 | 109,159 | 109,345 | 113,734 |
| Common Shares | 10,068 | 10,061 | 10,016 | 9,991 | 9,970 |
| Retained earnings | 1,404,448 | 1,350,453 | 1,305,593 | 1,262,239 | 1,219,386 |
| Other shareholders' equity | 15,884 | 16,520 | 20,434 | 19,283 | 13,966 |
| TOTAL | $549,591 | $631,295 | $636,257 | $617,535 | $589,941 |
| Total Liabilities And Equity | $1,164,071 | $1,132,638 | $1,103,602 | $1,093,351 | $1,067,317 |